Treatment of Alzheimer's disease by zinc compounds
- 1 January 1992
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 27 (1) , 1-14
- https://doi.org/10.1002/ddr.430270102
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Neuronal Localization of Copper-Zinc Superoxide Dismutase Protein and mRNA within the Human Hippocampus from Control and Alzheimer'S Disease BrainsFree Radical Research Communications, 1991
- Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's diseaseNeuroscience Letters, 1988
- THE SITE AND NATURE OF THE PRIMARY LESION IN ALZHEIMER??S DISEASEAlzheimer Disease & Associated Disorders, 1988
- WHAT, WHERE, AND WHY ARE PLAQUESAlzheimer Disease & Associated Disorders, 1988
- ENERGY-RELATED NEUROTOXICITY AT THE N-METHYL-D-ASPARTATE (NMDA) RECEPTORAlzheimer Disease & Associated Disorders, 1988
- Neutron activation analysis techniques for identifying elemental status in Alzheimer's diseaseJournal of Radioanalytical and Nuclear Chemistry, 1987
- Behavioral characteristics of rats experiencing chronic zinc deficiencyPhysiology & Behavior, 1979
- Effects of postnatal zinc deficiency on cerebellar and hippocampal development in the ratExperimental Neurology, 1977
- Zinc transport by transferrin in rat portal blood plasmaBiochemical and Biophysical Research Communications, 1975
- Zur Pathogenese des Postencephali-Tischen ParkinsonismusKlinische Wochenschrift, 1933